CrunchBase is hiring! Check out our open positions →
Register | Login or

General Information

Websiteaccelmed.co.il
Phone972-9-9588622
Email
Employees
Descriptioninvest in unique technologies

Funds

Offices

HQ
6 Hachoshlim St. 6 floor
P.O.Box 12006
Herzliya Pituach, 46120 , ISR

Tags

Accelmed Fund

Accelmed’s mission is to build state-of-the art medical device companies and lead them to success. We are looking to invest in unique technologies with significant market potential and proven clinical data.

Benefiting from the leadership of Mori Arkin and Uri Geiger, the co-founders of Accelmed, and the accumulated experience of our team, we are equipped to guide our portfolio companies with entrepreneurial, clinical, scientific, IP, financial, marketing and regulatory know-how towards the mutual end-goal of building a meaningful medical device business.

Concentrating on medical device companies which have already reached the revenue stage enables us to best assist companies in benefiting from our strong managerial capabilities and financial resources. Together with the management teams of our portfolio companies we can steer the way from the clinical stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.

Accelmed enjoys a unique position in today’s investment atmosphere. With actual funds available for immediate investment, we are looking to invest in promising enterprises.

Milestones

Investments

Company Date Round Size Participants
NLT SPINE 3/12Venture Round$5.7M2
CartiHeal 2/12Venture Round$5M2

Videos

Sources

  1. NLT SPINE Secures $5.7M in Funding (finsmes.com) [edit]
  2. CartiHeal Raises $5 Million in Financing to Support Agili-CTM For Single Stage Arthroscopic Cartilage Regeneration (in.finance.yahoo.com) [edit]
Edit This Page
Last Edited 4/8/12

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy